highly significantP = 0.0001
We next treated Aβ flies carrying a loss-of-function mutation of dFKBP59 , which showed a highly significant increase in lifespan, relative to non-BCS treated flies ( Fig. 4B ; P = 0.0001).
We next treated Aβ flies carrying a loss-of-function mutation of dFKBP59 , which showed a highly significant increase in lifespan, relative to non-BCS treated flies ( Fig. 4B ; P = 0.0001).